Best Thinking in Transportation Industry

Featured Content

• 
  Taxes Versus Tolls the Future of Transportation Finance
  Article by Dennis Polhill

  America's transportation system is the envy of the world. Yet, managers have failed to keep pace with growth. The ine...

• 
  Manual Transmissions, Though No Longer Standard, Still Selling
  Topic by Harvey K Black

  “Baby you can drive my car,” goes the Beatles’ song. But what if that vehicle has a manual transmission? Baby, can you drive it then? Before we answer that question, let's for the record note that a transmission does what it says. It transmits the power of the engine to the wheels of the...

• 
  Test Cars Are Driving Themselves Successfully
  Topic by Kate Prengaman

  It's like something out of a science fiction movie—cars that drive themselves without needing human control or even supervision. It's hard to imagine that a computer could learn to perform such a complex task—which involves maintaining and adjusting speed, turning, viewing obstacles, and...

• 
  Can Fracking Energy Benefits Outweigh Environmental Risks?
  Topic by Kate Prengaman

  Fracking has been all over the news recently. The term is a nickname for hydraulic fracturing, a controversial process for extracting natural gas from hard-to-reach underground deposits. Advances in drilling technology and discovery of new gas reserves have dramatically increased natural gas...

• 
  DOJ versus Apple versus Amazon on eBooks
  Topic by Carrie Kirby

  Oh, for the good old days of technology antitrust suits, when it was obvious which company was the bad cowboy and which one wore the white ten-gallon hat. It was easy to boo and hiss Bill Gates when he was the guy in the Department of Justice's cross hairs. But now that the DOJ has...

• 
  Pharmaceutical R&D Costs
  Topic by Dr Dennis Lendrem

  Pharmaceutical Research and Development is an expensive business.  Pharmaceutical companies recover R&D costs through extended patent protection and taxation allowances.  Estimates of R&D costs and the extent to which pharmaceutical companies are compensated for that investment are currently...